Format

Send to

Choose Destination
Crit Care Med. 2001 Apr;29(4 Suppl):N92-6.

Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall.

Author information

1
University of Chicago, the Department of Pediatrics, the Section of Pediatric Infectious Diseases, Chicago, IL, USA.

Abstract

Staphylococcus aureus is responsible for many nosocomial and community-acquired infections. Its evolving resistance to traditional antimicrobial chemotherapy and emerging prevalence outside of the healthcare environment are serious concerns. This review of the changing epidemiology of methicillin-resistant S. aureus, the emergence of vancomycin (glycopeptide)-resistant isolates, and the mechanisms of resistance to beta-lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center